← Back to Search

Brachytherapy

Radiation Therapy with CivaSheet® for Sarcoma

Phase 4
Recruiting
Led By Krisha Howell, MD
Research Sponsored by CivaTech Oncology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject is able to undergo surgery
Sarcoma evident on imaging. Pathology biopsy proven or suspected by imaging but not a biopsy candidate
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
Drug Has Already Been Approved
Pivotal Trial
No Placebo-Only Group

Summary

This trial will determine the safety and toxicity of a permanently implantable brachytherapy source, CivaSheet®, which delivers a therapeutic dose of low dose rate radiation with polymer encased Palladium-103.

Who is the study for?
This trial is for sarcoma patients who can have surgery and whose cancer appears in the retroperitoneum, abdomen, pelvis, or trunk. Participants must be able to stay under the care of the enrolling center and give informed consent. It's not open to those unwilling to follow protocol requirements, involved in other unapproved studies, or women who are pregnant or breastfeeding.
What is being tested?
The study is testing CivaSheet®, a device that's implanted during surgery and releases low dose rate radiation directly into the tumor area using Palladium-103. The goal is to see how safe it is and what side effects might occur when used in treating sarcomas located within specific body regions.
What are the potential side effects?
Potential side effects may include typical reactions associated with radiation therapy such as localized pain, swelling at implant site, infection risk increase around the surgical area where CivaSheet® is placed, and possible damage to nearby organs or tissues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am fit for surgery.
Select...
My scans show sarcoma, confirmed by biopsy or suspected but not biopsied.
Select...
My sarcoma is located in my abdomen, pelvis, trunk, or behind my abdomen.
Select...
My scans show a sarcoma, confirmed by biopsy or suspected but not biopsied.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of acute toxicity
Secondary study objectives
Complication rate
Dose to target and OAR
Local control rate
+1 more

Awards & Highlights

Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: CivaSheet TreatmentExperimental Treatment1 Intervention
Implanted with CivaSheet during tumor removal
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CivaSheet
2016
Completed Phase 1
~20

Find a Location

Who is running the clinical trial?

TAB ClinicalUNKNOWN
1 Previous Clinical Trials
25 Total Patients Enrolled
CivaTech OncologyLead Sponsor
6 Previous Clinical Trials
206 Total Patients Enrolled
Krisha Howell, MDPrincipal InvestigatorFox Chase Cancer Center
1 Previous Clinical Trials
11 Total Patients Enrolled

Media Library

CivaSheet (Brachytherapy) Clinical Trial Eligibility Overview. Trial Name: NCT04033081 — Phase 4
Sarcoma Research Study Groups: CivaSheet Treatment
Sarcoma Clinical Trial 2023: CivaSheet Highlights & Side Effects. Trial Name: NCT04033081 — Phase 4
CivaSheet (Brachytherapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04033081 — Phase 4
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top